These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 15474261)

  • 1. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
    Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
    Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian guidelines for the management of benign prostatic hyperplasia.
    Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
    Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the Diagnosis Improvement in Primary Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Cricelli C; Brenes F; Pedromingo-Marino A; Castro R
    Int J Clin Pract; 2009 Aug; 63(8):1192-7. PubMed ID: 19558487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in relation to the patient's risk profile for progression.
    Trachtenberg J
    BJU Int; 2005 Jun; 95 Suppl 4():6-11. PubMed ID: 15871730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
    Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
    Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BPH progression: concept and key learning from MTOPS, ALTESS, COMBAT, and ALF-ONE.
    Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():17-21. PubMed ID: 18307681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.
    Porru D; Scarpa RM; Prezioso D; Bertaccini A; Rizzi CA;
    Prostate Cancer Prostatic Dis; 2005; 8(1):45-9. PubMed ID: 15655566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diseases of the prostate in elderly patients. Benign prostate hyperplasia and prostate carcinoma].
    Madersbacher S
    Wien Med Wochenschr; 2001; 151(18-20):430-8. PubMed ID: 11817252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is botulinum neurotoxin type A (BoNT-A) a novel therapy for lower urinary tract symptoms due to benign prostatic enlargement? A review of the literature.
    Oeconomou A; Madersbacher H; Kiss G; Berger TJ; Melekos M; Rehder P
    Eur Urol; 2008 Oct; 54(4):765-75. PubMed ID: 18571306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic work-up of benign prostatic hyperplasia : The German S2e-guideline 2023 part 1].
    Oelke M; Abt SD; Becher KF; Dreikorn K; Madersbacher S; Magistro G; Michel MC; Muschter R; Reich O; Rieken M; Salem J; Schönburg S; Höfner K; Bschleipfer T
    Urologie; 2023 Aug; 62(8):805-817. PubMed ID: 37401972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of at-risk patients: dynamic variables.
    Emberton M
    BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
    Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
    Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple case definition of clinical benign prostatic hyperplasia, based on International Prostate Symptom Score, predicts general practitioner consultation rates.
    Kok ET; Bohnen AM; Jonkheijm R; Gouweloos J; Groeneveld FP; Thomas S; Bosch JL
    Urology; 2006 Oct; 68(4):784-9. PubMed ID: 17070353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.